Research led by scientists at the Rosalind Franklin Institute has shown that nanobodies—a smaller, simple form of antibody generated by llamas and camels—can effectively target the SARS-CoV-2 virus that causes COVID-19.

They found that short chains of the molecules, which can be produced in large quantities in the laboratory, significantly reduced signs of the COVID-19 disease when administered to infected animal models.

Read more...